Analysts Offer Insights on Consumer Cyclical Companies: Royal Caribbean (RCL) and Academy Sports and Outdoors (ASO)
There’s a lot to be optimistic about in the Consumer Cyclical sector as 2 analysts just weighed in on Royal Caribbean (RCL) and Academy Sports and Outdoors (ASO) with bullish sentiments.
Easter Sale - 70% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Royal Caribbean (RCL)
In a report released today, Benjamin Chaiken from Mizuho Securities maintained a Buy rating on Royal Caribbean, with a price target of $377.00. The company’s shares closed last Tuesday at $267.71, close to its 52-week high of $277.08.
According to TipRanks.com, Chaiken is a 3-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Royal Caribbean with a $366.47 average price target, implying a 35.3% upside from current levels. In a report issued on March 24, TipRanks – PerPlexity also reiterated a Buy rating on the stock with a $305.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
Academy Sports and Outdoors (ASO)
In a report released today, Jonathan Matuszewski from Jefferies reiterated a Buy rating on Academy Sports and Outdoors, with a price target of $66.00. The company’s shares closed last Tuesday at $57.18.
According to TipRanks.com, Matuszewski is a 4-star analyst with an average return of
Currently, the analyst consensus on Academy Sports and Outdoors is a Moderate Buy with an average price target of $60.18, representing a 2.8% upside. In a report issued on April 1, TipRanks – Google also upgraded the stock to Buy with a $63.00 price target.
Read More on RCL:
Disclaimer & DisclosureReport an Issue
- Royal Caribbean price target lowered to $377 from $379 at Mizuho
- Royal Caribbean price target lowered to $341 from $376 at JPMorgan
- Closing Bell Movers: Futures bounce on Iran ceasefire; Levi Strauss up 6% on Q1
- Morning Movers: Immunovant sinks after batoclimab trials miss goal
- Royal Caribbean price target lowered to $350 from $400 at TD Cowen
